| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |